Search

everythinglearnresearchcommunity

for

Search:↓

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Activating TRPV3 stops human hair growth.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

Skin fat helps with body temperature control and has other active roles in health.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Liposomes better deliver minoxidil for hair loss treatment than niosomes.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Mice without the Sept4/ARTS gene heal wounds better due to more stem cells that don't die easily.

A new gene, JMJD1C, may affect testosterone levels in men.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.